Mark Patrick Guerin Onconova Therapeutics, Inc. (ONTX) insider trading activity

Mark Patrick Guerin is CFO of Onconova Therapeutics, Inc.. Currently has a direct ownership of 39,255 shares of ONTX, which is worth approximately $23,160. The most recent transaction as insider was on Jun 18, 2024, when has been sold 2,221 shares (Common Stock) at a price of $0.47 per share, resulting in proceeds of $1,043. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.3K

9.11% 3M change

54.28% 12M change

Total Value Held $23,160

Mark Patrick Guerin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 18 2024	SELL Payment of exercise price or tax liability	$1,043 $0.47 p/Share	2,221 Reduced 5.35%	39,255 Common Stock
Jun 10 2024	BUY Exercise of conversion of derivative security	-	5,500 Added 11.71%	41,476 Common Stock
Mar 14 2024	SELL Payment of exercise price or tax liability	$2,331 $0.9 p/Share	2,591 Reduced 6.72%	35,976 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	-	8,666 Added 18.35%	38,567 Common Stock
Feb 07 2024	SELL Payment of exercise price or tax liability	$1,636 $0.67 p/Share	2,443 Reduced 7.55%	29,901 Common Stock
Feb 07 2024	BUY Exercise of conversion of derivative security	-	6,900 Added 17.58%	32,344 Common Stock
Aug 03 2023	SELL Payment of exercise price or tax liability	$1,450 $1.02 p/Share	1,422 Reduced 5.29%	25,444 Common Stock
Aug 02 2023	BUY Exercise of conversion of derivative security	-	4,750 Added 15.02%	26,866 Common Stock
Jun 12 2023	SELL Payment of exercise price or tax liability	$1,795 $1.14 p/Share	1,575 Reduced 6.65%	22,116 Common Stock
Jun 12 2023	BUY Exercise of conversion of derivative security	-	5,500 Added 18.84%	23,691 Common Stock
Feb 07 2023	SELL Payment of exercise price or tax liability	$2,427 $1.36 p/Share	1,785 Reduced 8.94%	18,191 Common Stock
Feb 07 2023	BUY Exercise of conversion of derivative security	-	6,900 Added 25.67%	19,976 Common Stock
Aug 03 2022	SELL Payment of exercise price or tax liability	$1,789 $1.32 p/Share	1,355 Reduced 9.39%	13,076 Common Stock
Aug 02 2022	BUY Exercise of conversion of derivative security	-	4,750 Added 24.76%	14,431 Common Stock
Feb 16 2021	BUY Open market or private purchase	$15,000 $1.0 p/Share	15,000 Added 9.36%	145,213 Common Stock
Nov 27 2020	BUY Open market or private purchase	$1,200 $0.26 p/Share	4,614 Added 3.42%	130,213 Common Stock
Nov 25 2020	BUY Open market or private purchase	$4,356 $0.26 p/Share	16,755 Added 11.77%	125,599 Common Stock

MPG

Mark Patrick Guerin

CFO

Newtown, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONTX shares.

Notify only if

Value

Insider Trading

Get notified when an Onconova Therapeutics, Inc. insider buys or sells ONTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Onconova Therapeutics, Inc.

Track Activities on ONTX

Account